ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

The FDA is considering a competency-based approach to evaluate generative AI-enabled medical devices, similar to doctor assessments. The discussion paper covers preapproval and postmarket regulation and solicits stakeholder feedback on the emerging technology's oversight.
Tap to vote and see what everyone thinks.
Summary by ByteBrief